Recent insights into extracorporeal photopheresis for graft-versus-host disease
C Del Fante, C Perotti - Expert Review of Clinical Immunology, 2024 - Taylor & Francis
ABSTRACT Introduction Extracorporeal Photopheresis (ECP) may be considered the unique
large-scale cell therapy currently available. It is currently employed mainly as second-line …
large-scale cell therapy currently available. It is currently employed mainly as second-line …
[HTML][HTML] Hottest topics in hematopoietic stem cell transplantation: a summary from the 8th International Transplant and Cellular Therapy Course
EU Suárez - Clinical Hematology International, 2023 - ncbi.nlm.nih.gov
The 8th International Transplant and Cellular Therapy Course of the European society for
Blood and Marrow Transplantation, EBMT) was held on September 8-10th, 2023, in …
Blood and Marrow Transplantation, EBMT) was held on September 8-10th, 2023, in …
The Future Directions of CAR-T Cell Therapy: Unlocking the Potential of Immunotherapy in Cancer Treatment
AA Justiz-Vaillant, S Soodeen, D Gopaul… - 2024 - preprints.org
CAR-T cell therapy has emerged as a groundbreaking approach in cancer treatment,
leveraging the immune system to target and eliminate cancer cells. While currently focused …
leveraging the immune system to target and eliminate cancer cells. While currently focused …
[PDF][PDF] REPURPOSING OF MULTIPLE SCLEROSIS (MS) AND GRAFT VERSUS HOST DISEASE (GVHD) THERAPEUTICS TO INHIBIT CHRONIC REJECTION OF …
M Kloc, A Uosef, M Halasa - scholar.archive.org
Chronic rejection of transplanted organs is an incurable event in transplantation.
Macrophages infiltrating allograft induce vessel occlusion and tissue fibrosis, which over the …
Macrophages infiltrating allograft induce vessel occlusion and tissue fibrosis, which over the …